SCHEMBL6028302

SCHEMBL6028302

CC(CN)CC[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6025051 0.80 CPB2 (0.31)
SCHEMBL16974378 0.78
SCHEMBL23429877 0.76 ALDH1A1 (0.40)
SCHEMBL20575074 0.76
SCHEMBL2954813 0.76 BHMT (0.32)
SCHEMBL349079 0.75
SCHEMBL351642 0.75
SCHEMBL2949069 0.74 BHMT (0.31)
SCHEMBL601259 0.74
SCHEMBL1890963 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2884985-A1 TOPICAL SKIN CARE COMPOSITION Jafer Limited (VG) 2015-06-24 EP claimed
WO-2014028032-A1 TOPICAL SKIN CARE COMPOSITION JAFER LIMITED (VG) 2014-02-20 WO claimed
EP-2884985-A1 TOPICAL SKIN CARE COMPOSITION Jafer Limited (VG) 2015-06-24 EP disclosed
WO-2014028032-A1 TOPICAL SKIN CARE COMPOSITION JAFER LIMITED (VG) 2014-02-20 WO disclosed
EP-1685142-A1 PHOSPHINIC ACID DERIVATIVES, BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2006-08-02 EP disclosed
WO-2005044830-A1 PHOSPHINIC ACIDS DERIVATIVES, BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2005-05-19 WO disclosed